Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY24 results · Jan–Mar 2024
Bajaj Healthcare reported revenue from operations of ₹133.90 crore (down 15.5% from Q4 FY23) and net loss of ₹29.92 crore for Q4 FY24 (Jan–Mar 2024), on a standalone basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 133.90 | 158.44 | −15.5% | 108.57 | +23.3% |
| Other income | 6.45 | 0.72 | +791.5% | 0.80 | +709.0% |
| Total income | 140.35 | 159.17 | −11.8% | 109.37 | +28.3% |
| Profit before tax | (35.15) | 5.00 | Turned loss | 6.33 | Turned loss |
| Net profit for the period | (29.92) | 3.59 | Turned loss | (2.20) | Loss widened |
| EPS, basic (₹) | (10.84) | 1.30 | Turned loss | (0.80) | Loss widened |
| Net margin (%) | -22.3 | 2.3 | -2.0 |
Standalone
- Filed with BSE
- 14 Jun 2024, 13:02 IST
- Board meeting
- 24 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE